Hepatotoxic herbs: Will injury mechanisms guide treatment strategies?

被引：10

作者：

Frazier T.H. ^{[1
]}

Krueger K.J. ^{[1
]}

机构：

[1] Department of Internal Medicine, Division of Gastroenterology and Hepatology, University of Louisville School of Medicine, Louisville, KY 40202

来源：

Current Gastroenterology Reports | 2009年 / 11卷 / 4期

关键词：

Mitochondrial Permeability Transition Pore; Fulminant Hepatic Failure; Mitochondrial Permeability Transition Pore; Usnic Acid; Hepatocellular Injury;

D O I：

10.1007/s11894-009-0046-y

中图分类号：

学科分类号：

摘要：

Harmful and fatal outcomes related to specific herbal therapies are reported with increasing regularity. However, US physicians remain inadequately informed about potential toxicities. The purpose of this focused review is to highlight past and more recently recognized herbal therapies or complementary and alternative medicine (CAM) that are shown to cause hepatotoxicity. Where available, the proposed mechanisms for toxicity are discussed. An aggressive approach for more stringent regulation of CAM is needed, in addition to a systematic and scientific study of causality and underlying toxic mechanisms, to provide reliable information about the safety of CAM and enable practitioners to deliver effective remedies when toxicities occur. © Current Medicine Group, LLC 2009.

引用

页码：317 / 324

页数：7

共 38 条

[1] Barnes P.M., Powell-Griner E., McFann K., Nahin R.L., Complementary and alternative medicine use among adults: United States, 2002, Adv Data, 343, pp. 1-19, (2004)
[2] Kennedy J., Herb and supplement use in the US adult population, Clin Ther, 27, pp. 1847-1858, (2005)
[3] Eisenberg D.M., Davis R.B., Ettner S.L., Et al., Trends in alternative medicine use in the United States, 1990-1997: Results of a follow-up national survey, JAMA, 280, pp. 1569-1575, (1998)
[4] Rhee S.M., Garg V.K., Hershey C.O., Use of complementary and alternative medicines by ambulatory patients, Arch Intern Med, 164, pp. 1004-1009, (2004)
[5] Fisher P., Van Haselen R., Hardy K., Et al., Effectiveness gaps: A new concept for evaluating health service and research needs applied to complementary and alternative medicine, J Altern Complement Med, 10, pp. 627-632, (2004)
[6] Sharples F., Van Haselen R., Fisher P., NHS Patients' perspective on complementary medicine, Complement Ther Med, 11, pp. 243-248, (2003)
[7] Astin J.A., Why patients use alternative medicine: Results of a national study, JAMA, 279, pp. 1548-1553, (1998)
[8] Zollman C., Vickers A., ABC of complementary medicine: Users and practitioners of complementary medicine, Br Med J, 319, pp. 836-838, (1999)
[9] Kennedy J., Wang C.C., Wu C.H., Patient disclosure about herb and supplement use among adults in the US, Evid Based Complement Alternat Med, 5, pp. 451-456, (2008)
[10] Estes J.D., Stolpman D., Olyaei A., Et al., High prevalence of potentially hepatotoxic herbal supplement use in patients with fulminant hepatic failure, Arch Surg, 138, pp. 852-858, (2003)

← 1 2 3 4 →